Loading…
Loading…
Tender Value
Refer Docs
Closing Date
7 Aug 2026, 11:30 amClosed
Single Packet
Normal Tender
No
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Rly. Board
Expenditure
General
MEDICAL
3 conditions · 3 needing a document upload
The offered product by the firm must be included in their product list uploaded on Railway Board website. If any firm offers a product which is not available in the Railway Board approved product list, that offer will be liable to be rejected.
The medicines and drugs are reserved to be purchased from firms registered with Railway Board and manufacturing unit of the offered product should be inspected and passed fit by Railway Board.
The tender enquiry is send to all the registered firms. Firms are advise to offer for the item. The offered product should be as per tender requirement
25 conditions · 7 needing a document upload
Please write/mention name & address of the marketing/importing agency with details of authorized distributor.
The firm will mention name(s) of specific stores of area where such drug is being sold in the open market. The zone will undertake random 5% check to establish that the product quoted by the firm is actually available in the store(s) mentioned by the firm. Further, if at the point of time of inspection such drug is not available in the Store (s) due sale of available stock, the retailer will be asked to provide a copy of purchase memo/supply order of the product from the firm.
The bidders are required to quote rates for one tablet/capsule.
The bidder confirms that rates and other financial terms quoted in relevant columns of financial bid will only be ruling terms for acceptance, and such terms quoted anywhere else should be ignored. (Denial of this condition not recommended).
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
By consignee after receipt.
This medicine is included in MII exemption list issued by ministry of finance, The tender shall be treated as global tender and offer from non local supplier is also acceptable as per MII policy.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
4 locations across Rajasthan · 850 Numbers total
Analogue Biphasic Insulin Mixture of Lispro 50% and Lispro Protamine 50%, 100IU/ml. 3ml. Cartridge for Reusable Insulin Delivery Device (PEN) *Reusable Insulin delivery device(Pen) to be supplied free of cost One pen free for every 25 cartridge)
82261295A
82261295A
Limited - Indigenous
Goods
Ajmer, Rajasthan
₹0
Exempted
7 Aug 2026
29 Jul 2026
1 item · 850 Numbers total
Analogue Biphasic Insulin Mixture of Lispro 50% and Lispro Protamine 50%, 100IU/ml. 3 ml. Cartridge for Reusable Insulin Delivery Device (PEN) *Reusable Insulin delivery device(Pen) to be s upplied free of cost One pen free for every 25 cartridge) ]
| Delivery Location | State | Quantity |
|---|---|---|
| AJMER DIVISIONAL HOSPITAL, NWR | Rajasthan | 30.00 Numbers |
| CENTRAL HOSPITAL JAIPUR, NWR | Rajasthan | 300.00 Numbers |
| CMS BIKANER, NWR | Rajasthan | 120.00 Numbers |
| JODHPUR DIVISIONAL HOSPITAL, NWR | Rajasthan | 400.00 Numbers |
| Total | 850 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5822216.pdf
ATTACHMENT
5818244.pdf
ATTACHMENT
5342849.pdf
ATTACHMENT
5659757.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .